IPad game aims to train young brains to fight OCD
NCT ID NCT06102941
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a game-like iPad program called cognitive control training (AKL-T01) in 60 children aged 8–12 with obsessive-compulsive disorder (OCD). For 4 weeks, kids play the game 25 minutes a day, 5 days a week, to improve focus and self-control. Researchers will check if this training reduces OCD symptoms and helps children respond better to standard therapy afterward.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AKL-T01 (cognitive control training via iPad game)
What this could lead to
If it works, this could point toward a non-drug, at-home treatment to reduce OCD symptoms and help kids get more out of standard therapy.
What could go wrong
This is a small, early study with only 60 children and no control group, so results may not be conclusive. The training is short (4 weeks) and may not produce lasting benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER IN CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center
RECRUITINGNew York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact